A5040314151- Cardiac, Anesthesia and Surgical Outcomes
- Aortic aneurysm repair treatments
- Aortic Disease and Treatment Approaches
- Peripheral Artery Disease Management
- Vascular Procedures and Complications
- Central Venous Catheters and Hemodialysis
- Venous Thromboembolism Diagnosis and Management
- Pancreatitis Pathology and Treatment
- Hip and Femur Fractures
- Pancreatic and Hepatic Oncology Research
- Renal cell carcinoma treatment
- Nerve injury and regeneration
- Infectious Aortic and Vascular Conditions
- Renal and Vascular Pathologies
- Cardiac tumors and thrombi
- Heart Failure Treatment and Management
- Cerebrovascular and Carotid Artery Diseases
- Cardiovascular Health and Disease Prevention
- Peripheral Nerve Disorders
- Diagnosis and Treatment of Venous Diseases
- Healthcare professionals’ stress and burnout
- Orthopedic Surgery and Rehabilitation
- Health Systems, Economic Evaluations, Quality of Life
- Vascular anomalies and interventions
- Neurogenesis and neuroplasticity mechanisms
University of Colorado Denver
2014-2019
University of Colorado Anschutz Medical Campus
2015-2018
University of Southern California
2018
Society for Vascular Surgery
2017
Johns Hopkins Hospital
2013-2016
Johns Hopkins University
2003-2015
University of California, Los Angeles
2015
Los Angeles Medical Center
2015
University of Maryland, Baltimore
2015
Rutgers, The State University of New Jersey
2015
The neurotrophin nerve growth factor (NGF) plays a crucial role in the development of sympathetic nervous system. In addition to being required for neuron survival vivo and vitro, NGF has been shown mediate axon vitro. vivo, however, is not clear because its requirement survival. This can be circumvented by concomitant deletion Bax, pro-apoptotic Bcl-2 family member, thus allowing an examination neurotrophins independently their function cell Here, we analyzed peripheral target organ...
The purpose is to determine whether patching during carotid endarterectomy (CEA) affects the perioperative and long-term risks of restenosis, stroke, death, myocardial infarction as compared with primary closure.We identified all patients who were randomized underwent CEA in Carotid Revascularization Endarterectomy versus Stenting Trial. received a patch closure without patch. We periprocedural 4-year event rates, 2-year restenosis rates reoperation between 2 groups. further analyzed results...